0001127602-18-025376.txt : 20180815 0001127602-18-025376.hdr.sgml : 20180815 20180815080533 ACCESSION NUMBER: 0001127602-18-025376 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180814 FILED AS OF DATE: 20180815 DATE AS OF CHANGE: 20180815 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ratcliffe Liam CENTRAL INDEX KEY: 0001547100 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37568 FILM NUMBER: 181019768 MAIL ADDRESS: STREET 1: C/O NEW LEAF VENTURE PARTNERS STREET 2: 7 TIMES SQUARE - SUITE 3502 CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edge Therapeutics, Inc. CENTRAL INDEX KEY: 0001472091 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264231384 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 CONNELL DRIVE STREET 2: SUITE 4000 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 BUSINESS PHONE: 800-208-3343 MAIL ADDRESS: STREET 1: 300 CONNELL DRIVE STREET 2: SUITE 4000 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2018-08-14 0001472091 Edge Therapeutics, Inc. EDGE 0001547100 Ratcliffe Liam C/O NEW LEAF VENTURES TIMES SQ. TWR., 7 TIMES SQUARE, STE 3502 NEW YORK NY 10036 1 Restricted Stock Units 2018-08-14 4 A 0 10000 0 A Common Stock 10000 10000 D Each restricted stock unit represents a contingent right to receive one share of Edge common stock upon the vesting of such unit. These restricted stock units shall become exercisable upon the achievement of certain performance or time based criteria. Expiration date is not applicable as the vested restricted stock units shall be settled on the first business day following the date that such restricted stock units vest. /s/ Albert N. Marchio II, attorney-in-fact 2018-08-15